Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.90 USD
Change Today -0.07 / -3.55%
Volume 113.9K
PSTI On Other Exchanges
Tel Aviv
As of 5:20 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank C. Carlucci

Head of Strategic Business Advisory Board,Pluristem Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 86 board members in 12 different organizations across 20 different industries.

See Board Relationships


Mr. Frank C. Carlucci is a Senior Advisor and Member of Advisory Board of Monument Capital Group Holdings LLC. He is a Co-Founder of Frontier Group. Mr. Carlucci serves as Counselor of Center for Strategic and International Studies, Inc. He served as a Managing Director of The Carlyle Group since 1989. Since 1993, Mr. Carlucci served as the Partner of The Carlyle Group and also served as its Vice Chairman from 1989 to 1993. He served as the Chief Executive Officer and ...

Read Full Background

Corporate Headquarters*

MATAM Advanced Technology Park
Haifa, -- 31905


Phone: 972 7 4710 8759
Fax: 972 7 4710 8765

Board Members Memberships*

Chairman Emeritus
Director and Member of Nominating and Corporate Governance Committee
Vice Chairman, Member of Compensation Committee, Member of Audit Committee and Member of Executive Committee
Vice Chairman, Member of Nomination & Corporate Governance Committee and Member of Compensation Committee


Unknown/Other Education
Harvard Business School
BA 1952
Princeton University
Honorary Doctorate 1989
University of Scranton

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PSTI:US $1.90 USD -0.07


Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Vericel Corporation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
Robin C. Stracey Chief Executive Officer and Director
Cesca Therapeutics Inc.
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PLURISTEM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at